North Highland Welcomes Nyla Beth Gawel as Senior Managing Director February 17, 2026 Gawel's appointment strengthens the firm's workforce strategy expertise
Corpay Cross-Border Named the Official Commercial FX Partner of Prima Pramac Racing February 17, 2026 Providing access to currency risk management and cross-border payments solutions
Allegion (NYSE: ALLE) Reports Q4, Full-Year 2025 Financial Results, Introduces 2026 Outlook February 17, 2026 High-Single Digit Revenue Growth for the Enterprise and Continued Strength in Americas Non-Residential Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $1.70, up 3.0% compared with $1.65; Adjusted EPS of $1.94, up 4.3% compared with $1.86 Revenues of $1,033.2 million, up 9.3% on a reported basis and up 3.3% on an organic basis Operating margin of 20.3%, compared with 19.5%; Adjusted operating margin of 22.4%, compared with 22.1% Full-Year Financial Highlights (All comparisons are year-over-year, unless otherwise noted) EPS of $7.44, up 9.1% compared with $6.82; Adjusted EPS of $8.14, up 8.1% compared with $7.53 Revenues of $4,067.3 million, up 7.8% on a reported basis and up 4.1% on an organic basis Operating margin of 21.1%, compared with 20.7%; Adjusted operating margin of 23.2%, up 40 basis points compared with 22.8% Available cash flow, which is defined as net cash from operating activities minus capital expenditures, was $685.7 million for 2025, an increase of 17.6% 2026 Full-Year Outlook Highlights Full-year reported revenue growth is estimated to be 5% to 7%, with organic revenue growth estimated to be 2% to 4% Full-year adjusted EPS is estimated to be $8.70 to $8.90 Available cash flow is estimated to be 85% to 95% of adjusted net income
Endava Partners with Miro to Drive Innovative New Model for AI Transformation February 17, 2026 Strategic partnership embeds Miro AI platform across Endava's global offering to strengthen its AI-native delivery model
FICO UK Credit Card Market Report: December 2025 February 17, 2026 Continued financial pressures evident as balances reach highest level since FICO records began
TNS Launches Market Data Usage Optimization Portal February 17, 2026 Transaction Network Services (TNS) today announced an upgrade to its TNS Data Usage Optimizer (DUO) with the launch of an interactive customer portal. Building on the launch of DUO in late 2024, this new interface offers buy-side and sell-side firms direct, on-demand access to the DUO portal to analyze market data subscriptions, identify unused services, [...]
K2 Partnering Solutions Appoints Srinivas Rao as Chief Executive Officer February 16, 2026 K2 Partnering Solutions, a global leader in consultative technology and talent solutions, today announced the appointment of Srinivas Rao as Chief Executive Officer. Srinivas is a seasoned global executive with more than 28 years of experience driving value creation, scalable growth, and operational transformation across digital, consulting, IT services, and business services. He brings deep [...]
Cahill Announces Arrival of Real Estate and Digital Infrastructure Finance Partner Lisa Seifman in the Firm’s London Office February 16, 2026 Cahill Gordon & Reindel LLP is pleased to announce that Lisa Seifman has joined the firm as a partner in the firm’s London office. Lisa will serve as Chair of Cahill’s Real Estate Finance practice group and Co-Chair of Cahill’s Digital Infrastructure Finance practice. Her arrival follows the recent addition of partner Jeremy Duffy, Chair [...]
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday February 16, 2026 A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes
Sultan bin Ahmed Visits Shanghai Film Studios, Film Park and Stadium February 15, 2026 His Highness Sheikh Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, visited the 800,000-square-metre Shanghai Film Studios and Film Park in the town of Shidon in the Chinese city of Shanghai on Saturday. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260215440594/en/ His [...]